Midgard Science
H

HitGen

Chengdu, China hitgen.com

From their website, Nov 2026

Work here? Claim this listing

About

HitGen is a drug discovery company based in Chengdu, China, with subsidiaries in Cambridge, UK, and Houston, USA. It serves pharmaceutical and biotechnology companies, chemical firms, foundations, and research institutions with DEL-based discovery, chemistry, biology, and preclinical services.

Services

  • DNA Encoded Library design and synthesis

    Designs and synthesizes DNA-encoded compound libraries for discovery and optimization programs.

    Assays & in vitro testing

  • DNA Encoded Library screening

    Uses DEL screening to identify small-molecule ligands for challenging targets.

    Assays & in vitro testing

  • OpenDEL

    Provides OpenDEL-enabled DEL discovery services as part of the company’s screening platform.

    Assays & in vitro testing

  • Nucleic acid sequence design

    Designs nucleic acid sequences to support oligonucleotide-based projects.

  • Monomer and solid support chemistry

    Provides chemistry support for monomers and solid supports used in nucleic acid and library work.

  • Oligonucleotide chemistry

    Supports oligonucleotide-related chemistry and conjugation work.

  • Nucleic acid delivery

    Develops conjugates and related chemistry for nucleic acid delivery applications.

  • CDMO

    Provides contract development and manufacturing services within its integrated discovery platform.

  • Protein degradation

    Integrates DEL, PROTAC synthesis, and biological validation for targeted protein degradation programs.

    Assays & in vitro testing

  • E3 ligases and their binders

    Identifies novel E3 ligases and develops binder toolboxes for protein degradation projects.

    Assays & in vitro testing

  • Discovery of molecular glue degraders

    Discovers molecular glue degraders and validates their function in protein degradation systems.

    Assays & in vitro testing

  • Discovery of proteolysis-targeting chimeras (PROTACs)

    Discovers and optimizes PROTACs using DEL screening and high-throughput synthesis.

    Assays & in vitro testing

  • Protein degrader evaluation

    Evaluates protein degraders using biochemical, biophysical, cell-based, and in vivo methods.

    Assays & in vitro testing

  • High throughput chemistry

    Performs high-throughput synthesis by combining combinatorial chemistry and parallel synthesis.

  • Synthetic chemistry

    Provides general synthetic chemistry services for drug discovery projects.

  • Peptide chemistry

    Offers peptide drug development services, including peptide and peptide-conjugate work.

  • Medicinal chemistry

    Provides early-stage drug discovery support including hit discovery and lead optimization.

  • Process chemistry

    Supports route design, process development, process safety, technology transfer, and non-GMP/GMP production.

  • Analytical chemistry and quality research

    Performs analytical characterization, purification, method development, quality control, and stability studies.

  • Computational chemistry

    Applies computational methods for virtual screening, scaffold hopping, and AI-enabled compound design.

  • Protein science

    Produces proteins, including E. coli, insect cell, mammalian cell, and yeast expression systems.

    Protein production

  • NGS and bioinformatics

    Provides sequencing and data analysis services, including DEL sequencing and multi-omics analysis.

  • Cell biology

    Offers cell model development, cell-based screening, target validation, and functional mechanism analysis.

    Assays & in vitro testing

  • Pre-clinical studies

    Provides in vivo pharmacokinetics, efficacy, and non-GLP toxicity evaluation.

  • Bioanalysis

    Supports bioanalysis across pharmacokinetics, pharmacodynamics, toxicology, and PCC determination.

  • Biological evaluation

    Carries out biological evaluation of discovered compounds.

    Assays & in vitro testing

  • FBDD/SBDD chemistry

    Uses fragment-based and structure-based drug discovery approaches for compound discovery and optimization.

  • Pre-clinical studies and bioanalysis

    Supports pre-clinical studies and bioanalysis, including DMPK and toxicity work.

Lead time
Under two days

Capabilities

As they state on their website or in their listing.

Processes
Small molecule · Peptide · Oligonucleotide · Gene editing · Oligonucleotides · Small molecules · NGS · Bioanalysis · Peptides · PK/PD · Toxicology · CRISPR
1 moreADME
Capacity
>1.2 Trillion DNA encoded compounds · Over 100,000 kinds of reagents · Over two hundred professional chemical synthesis personnel · Over 5,000 square meters laboratory hardware · 500㎡ BSL-2 laboratories · 200㎡ BSL-2 laboratories · Approximately 300m² BSL-2 cell culture laboratory · Over 50 different E3 ubiquitin ligases · More than 40 different target classes · Mg to g samples · Over 600 clients globally · Thousands of drug development projects
Scales
Milligram · Gram
Data supplied
NMR · LC-MS · HPLC

Equipment

  • Illumina NextSeq2000
  • Illumina NovaSeq6000
  • MGISEQ-2000
  • UPLC-MS
  • Prep-HPLC
  • NMR
  • LC-MS
  • GC-MS
  • SFC
  • HR LC-MS
  • High-content imaging system
  • Confocal microscope
  • Flow cytometer
  • Digital dispenser
  • Affinity Selection Mass Spectrometry (ASMS)
  • HPLC
  • Prep-SFC

Materials

  • E. coli
  • Yeast
  • Insect cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

Company

Type
CRO

Locations

Based in
Chengdu, China
Sites
Chengdu, China · Cambridge, United Kingdom · Houston, USA
Serves
global, global pharmaceutical industry

Similar labs

Work here? Claim this listing